VIGIL NEUROSCIENCE INC (VIGL) Stock Overview
USA - NASDAQ:VIGL - US92673K1088 - Common Stock
VIGL Key Statistics, Chart & Performance
The current stock price of VIGL is 8.05 USD. In the past month the price increased by 0.75%. In the past year, price increased by 170.13%.
VIGL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.02 | 393.22B | ||
| AMGN | AMGEN INC | 13.11 | 153.97B | ||
| GILD | GILEAD SCIENCES INC | 14.53 | 139.58B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.62 | 98.23B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.05 | 63.14B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.16B | ||
| ARGX | ARGENX SE - ADR | 79.83 | 45.29B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.9 | 40.16B | ||
| INSM | INSMED INC | N/A | 30.65B | ||
| NTRA | NATERA INC | N/A | 24.59B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.73B | ||
| BIIB | BIOGEN INC | 8.79 | 20.62B |
Related stock screener links
About VIGL
Company Profile
Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. The company is headquartered in Watertown, Massachusetts and currently employs 69 full-time employees. The company went IPO on 2022-01-07. The firm is focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. The company is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based therapies to improve the lives of patients and their families. Its lead clinical candidate, VGL101 (iluzanebart), is a fully human monoclonal antibody TREM2 agonist that is being studied in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. The firm is also developing VG-3927, its orally available small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer’s disease in genetically defined subpopulations.
Company Info
VIGIL NEUROSCIENCE INC
100 Forge Road, Suite 700
Watertown MASSACHUSETTS US
Employees: 69
Phone: 18572544445
VIGIL NEUROSCIENCE INC / VIGL FAQ
What is the stock price of VIGIL NEUROSCIENCE INC today?
The current stock price of VIGL is 8.05 USD.
What is the ticker symbol for VIGIL NEUROSCIENCE INC stock?
The exchange symbol of VIGIL NEUROSCIENCE INC is VIGL and it is listed on the Nasdaq exchange.
On which exchange is VIGL stock listed?
VIGL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VIGIL NEUROSCIENCE INC stock?
13 analysts have analysed VIGL and the average price target is 8.16 USD. This implies a price increase of 1.37% is expected in the next year compared to the current price of 8.05. Check the VIGIL NEUROSCIENCE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VIGIL NEUROSCIENCE INC worth?
VIGIL NEUROSCIENCE INC (VIGL) has a market capitalization of 375.69M USD. This makes VIGL a Small Cap stock.
How many employees does VIGIL NEUROSCIENCE INC have?
VIGIL NEUROSCIENCE INC (VIGL) currently has 69 employees.
What are the support and resistance levels for VIGIL NEUROSCIENCE INC (VIGL) stock?
VIGIL NEUROSCIENCE INC (VIGL) has a support level at 8.04 and a resistance level at 8.05. Check the full technical report for a detailed analysis of VIGL support and resistance levels.
Should I buy VIGIL NEUROSCIENCE INC (VIGL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VIGL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VIGL, evaluating the profitability, health, valuation and growth aspects
- VIGIL NEUROSCIENCE INC (VIGL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIGIL NEUROSCIENCE INC (VIGL) Sales and EPS estimates to see what analysts future expectations are.
- VIGIL NEUROSCIENCE INC (VIGL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIGIL NEUROSCIENCE INC (VIGL) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIGIL NEUROSCIENCE INC (VIGL) Stock Chart to make your own analysis
- VIGIL NEUROSCIENCE INC (VIGL) Latest news and press-releases to stay up to date.
Does VIGIL NEUROSCIENCE INC (VIGL) stock pay dividends?
VIGL does not pay a dividend.
When does VIGIL NEUROSCIENCE INC (VIGL) report earnings?
VIGIL NEUROSCIENCE INC (VIGL) will report earnings on 2025-11-03.
What is the Price/Earnings (PE) ratio of VIGIL NEUROSCIENCE INC (VIGL)?
VIGIL NEUROSCIENCE INC (VIGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.09).
VIGL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to VIGL. When comparing the yearly performance of all stocks, VIGL is one of the better performing stocks in the market, outperforming 98.76% of all stocks.
VIGL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VIGL. The financial health of VIGL is average, but there are quite some concerns on its profitability.
VIGL Financial Highlights
Over the last trailing twelve months VIGL reported a non-GAAP Earnings per Share(EPS) of -2.09. The EPS increased by 1.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -80.94% | ||
| ROE | -133.18% | ||
| Debt/Equity | 0 |
VIGL Forecast & Estimates
13 analysts have analysed VIGL and the average price target is 8.16 USD. This implies a price increase of 1.37% is expected in the next year compared to the current price of 8.05.